<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">phkinetica</journal-id><journal-title-group><journal-title xml:lang="ru">Фармакокинетика и Фармакодинамика</journal-title><trans-title-group xml:lang="en"><trans-title>Pharmacokinetics and Pharmacodynamics</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2587-7836</issn><issn pub-type="epub">2686-8830</issn><publisher><publisher-name>ООО «Издательство ОКИ»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24411/2587-7836-2019-10035</article-id><article-id custom-type="elpub" pub-id-type="custom">phkinetica-82</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МЕХАНИЗМ ДЕЙСТВИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>MECHANISM OF ACTION</subject></subj-group></article-categories><title-group><article-title>Исследование протекторных свойств агониста TrkA-рецептора ГК-2 на модели окислительного стресса в культуре клеток сосудистого эндотелия человека (HUVEC)</article-title><trans-title-group xml:lang="en"><trans-title>Research of neuroprotective properties of TrkA-receptor agonist GK-2 on model of oxidative stress in human vascular endothelial cells (HUVEC)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Антипова</surname><given-names>Т. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Antipova</surname><given-names>T. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Николаев</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Nikolaev</surname><given-names>S. V.</given-names></name></name-alternatives><email xlink:type="simple">cergej.nikolajev@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Крыжановский</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kryzhanovsky</surname><given-names>S. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пекельдина</surname><given-names>Е. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Pekeldina</surname><given-names>E. S.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательский институт фармакологии имени В.В. Закусова»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>FSBI «Zakusov Institute of Pharmacology»</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>06</day><month>01</month><year>2019</year></pub-date><volume>0</volume><issue>1</issue><fpage>18</fpage><lpage>21</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Антипова Т.А., Николаев С.В., Крыжановский С.А., Пекельдина Е.С., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Антипова Т.А., Николаев С.В., Крыжановский С.А., Пекельдина Е.С.</copyright-holder><copyright-holder xml:lang="en">Antipova T.A., Nikolaev S.V., Kryzhanovsky S.A., Pekeldina E.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pharmacokinetica.ru/jour/article/view/82">https://www.pharmacokinetica.ru/jour/article/view/82</self-uri><abstract><p>Окислительный стресс приводил к достоверному снижению жизнеспособности клеток по сравнению с контролем (78±5 % и 100±6 % соответственно, р &lt; 0,05). Внесение как ГК-2, так и NGF предотвращало снижение жизнеспособности клеток HUVEC под действием H2O2 (95±3 % для ГК-2 и 97±4 % для NGF против 78±5 % для H2O2, р &lt; 0,05). В контроле количество клеток с конденсированным хроматином составило 9±2, после внесения Н2О2 78±9 (р &lt; 0,05 по сравнению с контролем). Внесение NGF или ГК-2 после Н2О2 достоверно снижало число таких клеток (44±9 и 41±8 соответственно) (р &lt; 0,05 по сравнению с перекисью водорода) и препятствовало развитию морфологических изменений ядерного хроматина. Таким образом, ГК-2, подобно NGF, в культуре клеток эндотелия человека HUVEC препятствует развитию процесса апоптоза, вызванного окислительным стрессом.</p></abstract><trans-abstract xml:lang="en"><p>Oxidative stress resulted to decrease in cells viability compared to the control (78 ± 5 % and 100 ± 6 %, respectively, р &lt; 0,05). GK-2 and NGF prevented H2O2-induced HUVEC cells damages (95 ± 3 % for HA-2 and 97 ± 4 % for NGF vs. 78 ± 5 % for H2O2, p &lt; 0.05). In control the number of cells with condensed chromatin was 9 ± 2, after the addition of H2O2 78 ± 9 (p &lt; 0.05 compared with the control). The addition of NGF or GK-2 after H2O2 significantly reduced the number of such cells (44 ± 9 and 41 ± 8, respectively) (p &lt; 0.05 compared to hydrogen peroxide) and prevented the development of morphological changes in nuclear chromatin. Thus GK-2, like NGF, in human endothelial cell culture HUVEC prevented the apoptosis development caused by hydrogen peroxide.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>NGF</kwd><kwd>димерный дипептидный миметик ГК-2</kwd><kwd>HUVEC клетки эндотелия человека</kwd><kwd>окислительный стресс</kwd><kwd>апоптоз</kwd><kwd>NGF</kwd><kwd>dimeric dipeptide mimetic GK-2</kwd><kwd>HUVEC</kwd><kwd>oxidative stress</kwd><kwd>apoptosis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Парфенова Е.В., Ткачук В.А. Терапевтический ангтогенез: достижения, проблемы, перспективы // Кардиологический вестник. – 2017. – Т. 2. – № 2(14). – С. 5–14. [Parfenova EV, Tkachuk VA. Therapeutic angiogenesis: advances, problems, prospects. Kardiologicheskij vestnik. 2007;2(2(14)):5–15. (In Russ).]</mixed-citation><mixed-citation xml:lang="en">Парфенова Е.В., Ткачук В.А. Терапевтический ангтогенез: достижения, проблемы, перспективы // Кардиологический вестник. – 2017. – Т. 2. – № 2(14). – С. 5–14. [Parfenova EV, Tkachuk VA. Therapeutic angiogenesis: advances, problems, prospects. Kardiologicheskij vestnik. 2007;2(2(14)):5–15. (In Russ).]</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ko SH, Bandyk DF. Therapeutic angiogenesis for critical limb ischemia. Semin. Vasc. Surg. 2014;27:1:23–31.</mixed-citation><mixed-citation xml:lang="en">Ko SH, Bandyk DF. Therapeutic angiogenesis for critical limb ischemia. Semin. Vasc. Surg. 2014;27:1:23–31.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Blais M, L vesque P, Bellenfant S, Berthod F. Nerve growth factor, brain-derived neurotrophic factor, neurotrophin-3 and glial-derived neurotrophic factor enhance angiogenesis in a tissue-engineered in vitro model. TissueEng. PartA. 2013;19(15–16):1655–1664.</mixed-citation><mixed-citation xml:lang="en">Blais M, L vesque P, Bellenfant S, Berthod F. Nerve growth factor, brain-derived neurotrophic factor, neurotrophin-3 and glial-derived neurotrophic factor enhance angiogenesis in a tissue-engineered in vitro model. TissueEng. PartA. 2013;19(15–16):1655–1664.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Гудашева Т.А., Антипова Т.А., Середенин С.Б. Новые низкомолекулярные миметики фактора роста нервов // ДАН. – 2010. – Т. 434. – № 4. – С. 549–552. [Gudasheva TA, Antipova TA, Seredenin SB. Novel low-molecular-weight mimetics of the nerve growth factor. Doklady Biochemistry and Biophysics. 2010;434(4):549–552. (In Russ).]</mixed-citation><mixed-citation xml:lang="en">Гудашева Т.А., Антипова Т.А., Середенин С.Б. Новые низкомолекулярные миметики фактора роста нервов // ДАН. – 2010. – Т. 434. – № 4. – С. 549–552. [Gudasheva TA, Antipova TA, Seredenin SB. Novel low-molecular-weight mimetics of the nerve growth factor. Doklady Biochemistry and Biophysics. 2010;434(4):549–552. (In Russ).]</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Крыжановский С.А., Антипова Т.А., Цорин И.Б., и др. Ангиогенные эффекты димерного дипептидного миметика четвертой петли фактора роста нервов // Бюл. эксперим. биол. и медицины. – 2016. – Т. 161. – № 4. – С. 503–507. [Kryzhanovskii SA, Antipova TA, Tsorin IB. Angiogenic effects of dimeric dipeptide mimetic of loop 4 of nerve growth factor. Bulletin of Experimental Biology and Medicine. 2016;161(4):513–517. (In Russ).]</mixed-citation><mixed-citation xml:lang="en">Крыжановский С.А., Антипова Т.А., Цорин И.Б., и др. Ангиогенные эффекты димерного дипептидного миметика четвертой петли фактора роста нервов // Бюл. эксперим. биол. и медицины. – 2016. – Т. 161. – № 4. – С. 503–507. [Kryzhanovskii SA, Antipova TA, Tsorin IB. Angiogenic effects of dimeric dipeptide mimetic of loop 4 of nerve growth factor. Bulletin of Experimental Biology and Medicine. 2016;161(4):513–517. (In Russ).]</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases:the role of oxidant stress. Circ. Res. 2000;87(10)840–844.</mixed-citation><mixed-citation xml:lang="en">Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases:the role of oxidant stress. Circ. Res. 2000;87(10)840–844.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Berry C, Brosnan MJ, Fennell JP, et al. Oxidative stress and vascular damage in hypertension. Curr. Opin. Nephrol. Hypertens. 2001;10(2):247–255.</mixed-citation><mixed-citation xml:lang="en">Berry C, Brosnan MJ, Fennell JP, et al. Oxidative stress and vascular damage in hypertension. Curr. Opin. Nephrol. Hypertens. 2001;10(2):247–255.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Twentyman PR, Luscombe M. A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. Br. J. Cancer. 1987;56:279–285.</mixed-citation><mixed-citation xml:lang="en">Twentyman PR, Luscombe M. A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. Br. J. Cancer. 1987;56:279–285.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Mu P, Liu Q, Zheng R. Biphasic regulation of H2O2 on angiogenesis implicated NADPH oxidase. CellBiologyInternational. 2010;34(10):1013–1020.</mixed-citation><mixed-citation xml:lang="en">Mu P, Liu Q, Zheng R. Biphasic regulation of H2O2 on angiogenesis implicated NADPH oxidase. CellBiologyInternational. 2010;34(10):1013–1020.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Антипова Т.А. Нейропротекторное действие низкомолекулярного пептидного миметика фактора роста нервов NGF ГК-2 связано с активацией синтеза белков теплового шока HSP32 и HSP70 и увеличением фосфорилирования TrkA // Эксперим. и клин. фармакол. – 2010. – Т. 73. – № 12. – С. 6–8. [Antipova TA. Neuroprotective effect of lowmolecular peptide mimetic (GK-2) of nerve growth factor is related to activated synthesis of heat shock proteins (HSP32 and HSP70) and increased phosphorylation of TrkA receptor. Eksperim. i klin. Farmakol. 2010;73(12):6–8. (In Russ).] DOI: https://doi.org/10.30906/0869-2092-2010-73-12-6-8.</mixed-citation><mixed-citation xml:lang="en">Антипова Т.А. Нейропротекторное действие низкомолекулярного пептидного миметика фактора роста нервов NGF ГК-2 связано с активацией синтеза белков теплового шока HSP32 и HSP70 и увеличением фосфорилирования TrkA // Эксперим. и клин. фармакол. – 2010. – Т. 73. – № 12. – С. 6–8. [Antipova TA. Neuroprotective effect of lowmolecular peptide mimetic (GK-2) of nerve growth factor is related to activated synthesis of heat shock proteins (HSP32 and HSP70) and increased phosphorylation of TrkA receptor. Eksperim. i klin. Farmakol. 2010;73(12):6–8. (In Russ).] DOI: https://doi.org/10.30906/0869-2092-2010-73-12-6-8.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Stankiewicz AR, Lachapelle G, Foo CP, et al. Hsp70 inhibits heatinduced apoptosis upstream of mitochondria by preventing Bax translocation. J. Biol. Chem. 2005;280(46):38729-38739.</mixed-citation><mixed-citation xml:lang="en">Stankiewicz AR, Lachapelle G, Foo CP, et al. Hsp70 inhibits heatinduced apoptosis upstream of mitochondria by preventing Bax translocation. J. Biol. Chem. 2005;280(46):38729-38739.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Saleh A, Srinivasula SM, Balkir L, Robbins PD, Alnemri ES. Negative regulation of the APAF-1 apoptosome by HSP70. Nat. Cell Biology. 2000;2(8):476–483.</mixed-citation><mixed-citation xml:lang="en">Saleh A, Srinivasula SM, Balkir L, Robbins PD, Alnemri ES. Negative regulation of the APAF-1 apoptosome by HSP70. Nat. Cell Biology. 2000;2(8):476–483.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kalinowska M, Garncarz W, Pietrowska M, et al. Regulation of the human apoptotic DNase/RNase Endonuclease G: Involvement of Hsp70 and ATP. Apoptosis. 2005;10(4):821–830.</mixed-citation><mixed-citation xml:lang="en">Kalinowska M, Garncarz W, Pietrowska M, et al. Regulation of the human apoptotic DNase/RNase Endonuclease G: Involvement of Hsp70 and ATP. Apoptosis. 2005;10(4):821–830.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
